Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effects of tiludronate on bone loss in paraplegic patients.
Chappard D, Minaire P, Privat C, Berard E, Mendoza-Sarmiento J, Tournebise H, Basle MF, Audran M, Rebel A, Picot C, et al. Chappard D, et al. Among authors: tournebise h. J Bone Miner Res. 1995 Jan;10(1):112-8. doi: 10.1002/jbmr.5650100116. J Bone Miner Res. 1995. PMID: 7747617 Free article. Clinical Trial.
Paraplegia and decompression sickness.
Tournebise H, Boucand MH, Landi J, Theobald X. Tournebise H, et al. Paraplegia. 1995 Nov;33(11):636-9. doi: 10.1038/sc.1995.134. Paraplegia. 1995. PMID: 8584297
[Intensive care ... and after?].
Boucand MH, Tournebise H. Boucand MH, et al. Among authors: tournebise h. Agressologie. 1990;31(10):725-6. Agressologie. 1990. PMID: 2099643 French.
[Hyperparathyroidism induced by lithium. A new case].
Pieri-Balandraud N, Hugueny P, Henry JF, Tournebise H, Dupont C. Pieri-Balandraud N, et al. Among authors: tournebise h. Rev Med Interne. 2001 May;22(5):460-4. doi: 10.1016/s0248-8663(01)00371-x. Rev Med Interne. 2001. PMID: 11402517 French.
Botulinum Toxin Type A Injection After Failure of Augmentation Enterocystoplasty Performed for Neurogenic Detrusor Overactivity: Preliminary Results of a Salvage Strategy. The ENTEROTOX Study.
Michel F, Ciceron C, Bernuz B, Boissier R, Gaillet S, Even A, Chartier-Kastler E, Denys P, Gamé X, Ruffion A, Normand LL, Perrouin-Verbe B, Saussine C, Manunta A, Forin V, De Seze M, Grise P, Tournebise H, Schurch B, Karsenty G. Michel F, et al. Among authors: tournebise h. Urology. 2019 Jul;129:43-47. doi: 10.1016/j.urology.2019.03.010. Epub 2019 Mar 26. Urology. 2019. PMID: 30926380
Résultats du changement de marque de toxine botulinique de type A (TBA), Botox(®) vers Dysport(®), dans le traitement de l'hyperactivité détrusorienne neurogène (HDN).
Bottet F, Peyronnet B, Game X, Manunta A, Ruffion A, Perrouin-Verbe B, Reiss B, Previnaire J, Tournebise H, Bernuz B, Lenne K, Lechevallier E, Karsenty G. Bottet F, et al. Among authors: tournebise h. Prog Urol. 2015 Nov;25(13):737. doi: 10.1016/j.purol.2015.08.043. Prog Urol. 2015. PMID: 26544238 French. No abstract available.
13 results